Trial Profile
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of AZD5985 in Healthy Male Subjects
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2009
Price :
$35
*
At a glance
- Drugs AZD 5985 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 14 Nov 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 Sep 2009 New trial record